News

EU authorises Novavax as fifth Covid vaccine


Novavax’s jab is a protein-based vaccine of the kind used around the world to protect against many childhood illnesses

The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.

– ‘Promising results’ – Earlier Monday, the European Medicines Agency (EMA) gave the green light for the jab to be given conditional marketing authorisation.

Originally published as EU authorises Novavax as fifth Covid vaccine



Source link

Leave a Reply

Your email address will not be published.

close